Commission Regulation (EU) 2026/78 materially tightens the EU Cosmetics Regulation by operationalising the automatic prohibition and restriction of substances classified as carcinogenic, mutagenic or toxic for reproduction (CMR). Effective 1 May 2026, the Regulation adds 15 substances to Annex II (Prohibited Substances), introduces new restrictions and exemptions for silver, places Hexyl Salicylate under strict use conditions, and expands the preservative framework by allowing Sodium o-Phenylphenate alongside o-Phenylphenol under defined limits.
For cosmetic companies exporting to Europe, the Regulation establishes a hard stop on placing non-compliant products on the EU market from 1 May 2026, with no grace period for reformulation or sell-through. Beyond Europe, the Regulation has predictive reach: EU-inspired regulatory systems across Africa increasingly align their prohibited and restricted substance lists with EU annex updates, making this Regulation a leading indicator of future African regulatory convergence.
Companies that proactively translate these changes into ingredient governance, portfolio rationalisation and supplier accountability will not only preserve EU market access but gain first-mover advantage in African markets that mirror EU cosmetic safety principles.
Key Regulatory Highlights for Cosmetics Companies Exporting to Europe and EU Following Markets
Preservatives – Annex V Expansion:
Sodium o-Phenylphenate is added alongside o-Phenylphenol, permitted at the same maximum authorised concentrations, with cumulative caps and inhalation/oral exposure prohibitions clearly articulated.
Strategic Spillover into Africa
Many African regulators reference EU annexes as technical benchmarks, even where not legally transposed. This Regulation therefore:
Compliance Timeline & Recommended Actions Your Company Should Have Been On
Q3 2024
Q4 2024 – Q2 2025
Q3 2025 – Q1 2026
By 1 May 2026
Bottom Line
EU 2026/78 is not a routine annex update—it is a structural tightening of the EU’s CMR enforcement model with global regulatory ripple effects. Companies that treat this Regulation as a strategic inflection point, rather than a technical hurdle, will protect EU access, streamline African expansion and reinforce brand trust in an increasingly safety-led cosmetic economy.